![John D. Iuliucci](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Profil
John D.
Iuliucci worked as a Senior Toxicologist at Warner-Lambert Pharmaceutical Research Institute from 1972 to 1995.
He was the Head of the Drug Safety Evaluation Department at Adria Laboratories from 1975 to 1984.
From 1984 to 1992, he worked as the Director of Preclinical Pharmacology & Toxicology at Centocor, Inc. He then worked as the Chief Development Officer & Senior Vice President at ARIAD Pharmaceuticals, Inc. from 1992 to 2011.
Dr. Iuliucci received his undergraduate, graduate, and doctorate degrees from Temple University (Pennsylvania).
Anciens postes connus de John D. Iuliucci
| Sociétés | Poste | Fin |
|---|---|---|
Warner-Lambert Pharmaceutical Research Institute | Corporate Officer/Principal | 01/01/1995 |
Centocor, Inc.
 Centocor, Inc. Medical SpecialtiesHealth Technology Manufactures healthcare products | Corporate Officer/Principal | 01/01/1992 |
Adria Laboratories | Corporate Officer/Principal | 01/01/1984 |
| ARIAD PHARMACEUTICALS, INC. | Corporate Officer/Principal | - |
Formation de John D. Iuliucci
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
20
Relations au 1er degré
5
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 5 |
|---|---|
Centocor, Inc.
Centocor, Inc. Medical SpecialtiesHealth Technology Manufactures healthcare products | Health Technology |
ARIAD Pharmaceuticals, Inc.
 ARIAD Pharmaceuticals, Inc. BiotechnologyHealth Technology Discovers, develops and commercializes small-molecule drugs for the treatment of cancer | Health Technology |
Temple University (Pennsylvania)
 Temple University (Pennsylvania) Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Adria Laboratories | |
Warner-Lambert Pharmaceutical Research Institute |
